Biotherapies in systemic lupus erythematosus: New targets
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference54 articles.
1. Further thoughts about the ILLUMINATE studies of tabalumab in SLE;Isenberg;Ann Rheum Dis,2016
2. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial;Merrill;Arthritis Rheum,2010
3. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study;Rovin;Arthritis Rheum,2012
4. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study;Genovese;Arthritis Rheum,2008
5. Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study;Mysler;Arthritis Rheum,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus;Expert Review of Clinical Immunology;2023-10-11
2. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis;Science Translational Medicine;2021-06-30
3. Review article: experimental therapies in autoimmune hepatitis;Alimentary Pharmacology & Therapeutics;2020-08-14
4. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014;Autoimmunity Reviews;2020-06
5. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review;BioMed Research International;2019-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3